Moderna Expands Partnership to Develop Vaccine for Rare Ebola Virus Strain, CEPI Commits Up to $50M to Support Early Testing and Manufacturing of Experimental Ebola Shot

Loading news article.

Moderna Expands Partnership to Develop Vaccine for Rare Ebola Virus Strain, CEPI Commits Up to $50M to Support Early Testing and Manufacturing of Experimental Ebola Shot | WAPE

Moderna Expands Partnership to Develop Vaccine for Rare Ebola Virus Strain, CEPI Commits Up to $50M to Support Early Testing and Manufacturing of Experimental Ebola Shot

Article summary

Related companies

Comments —